Compare COO & REG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | COO | REG |
|---|---|---|
| Founded | 1980 | 1963 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Ophthalmic Goods | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.5B | 12.8B |
| IPO Year | N/A | 1993 |
| Metric | COO | REG |
|---|---|---|
| Price | $81.98 | $68.93 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 11 |
| Target Price | ★ $85.82 | $78.90 |
| AVG Volume (30 Days) | ★ 3.3M | 1.1M |
| Earning Date | 12-04-2025 | 10-28-2025 |
| Dividend Yield | N/A | ★ 4.40% |
| EPS Growth | N/A | ★ 2.61 |
| EPS | 1.87 | ★ 2.18 |
| Revenue | ★ $4,092,400,000.00 | $1,576,868,000.00 |
| Revenue This Year | $6.66 | $3.11 |
| Revenue Next Year | $5.54 | $4.13 |
| P/E Ratio | $43.53 | ★ $31.52 |
| Revenue Growth | 5.06 | ★ 5.84 |
| 52 Week Low | $61.78 | $63.44 |
| 52 Week High | $104.47 | $78.18 |
| Indicator | COO | REG |
|---|---|---|
| Relative Strength Index (RSI) | 72.89 | 37.54 |
| Support Level | $75.25 | $70.64 |
| Resistance Level | $78.69 | $71.75 |
| Average True Range (ATR) | 2.48 | 1.02 |
| MACD | 0.47 | -0.10 |
| Stochastic Oscillator | 55.39 | 3.37 |
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.
Regency Centers is one of the largest shopping center-focused retail REITs. The company's portfolio includes an interest in 483 properties, which includes over 57 million square feet of retail space following the completion of the Urstadt Biddle acquisition in August 2023. The portfolio is geographically diversified with 22 regional offices and no single market representing more than 12% of total company net operating income. Regency's retail portfolio is primarily composed of grocery-anchored centers, with 80% of properties featuring a grocery anchor and grocery stores representing 20% of annual base rent.